Literature DB >> 7537916

Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control.

M Steiner1, K M Reinhardt, B Krammer, B Ernst, A D Blann.   

Abstract

Patients with Type 2 (non-insulin dependent) diabetes mellitus are at increased risk of thrombosis and the premature development of atherosclerosis. This may be related to damage to the endothelium (which may be the primary target tissue for the disease process) resulting from a loss of normal glycaemic metabolic control. Thus changes in endothelial cell function, such as modified release of soluble leukocyte and platelet adhesion molecules, may be important. Accordingly, E-selectin, von Willebrand factor (vWf), vascular cell adhesion molecule (VCAM) and intercellular adhesion molecule (ICAM) were measured in serum from 60 patients and 76 controls. Raised levels of vWf (p = 0.0002), E-selectin (p < 0.0001) and VCAM (p = 0.003) in patient's samples failed to correlate with glycaemic control as assessed by levels of fructosamine and glycated haemoglobin, or with 24 h urine albumin. Levels of ICAM were not increased in our patients. Levels of the two endothelial cell products, vWf and E-selectin, failed to correlate although E-selectin correlated with low density lipoprotein cholesterol (p = 0.016). vWf correlated with VCAM (p < 0.001) and hypertension (p = 0.032). We conclude that levels of soluble adhesion molecules vWf, E-selectin and VCAM are raised in Type 2 diabetes mellitus. The mechanisms for these changes appear to be independent of glycaemic control but may relate to concurrent hypertension and/or hypercholesterolaemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7537916

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  20 in total

Review 1.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Losartan and simvastatin inhibit platelet activation in hypertensive patients.

Authors:  Shosaku Nomura; Akira Shouzu; Seitarou Omoto; Mitsushige Nishikawa; Shirou Fukuhara; Toshiji Iwasaka
Journal:  J Thromb Thrombolysis       Date:  2004-12       Impact factor: 2.300

3.  Soluble adhesion molecules in NIDDM: increased concentration, relation to glycometabolic control and possible pathophysiological significance.

Authors:  M Steiner; K M Reinhardt; A D Blann
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

4.  Elevated circulating adhesion molecules in NIDDM--potential mediators in diabetic macroangiopathy.

Authors:  P Fasching; W Waldhäusl; O F Wagner
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

5.  Increased levels of plasma ELAM-1, ICAM-1 and VCAM-1 in NIDDM: possible role of oxidized LDL.

Authors:  L Cominacini; U Garbin; A Fratta Pasini; V Lo Cascio
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

6.  Significance of chemokines and activated platelets in patients with diabetes.

Authors:  S Nomura; A Shouzu; S Omoto; M Nishikawa; S Fukuhara
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

7.  Enhancement of endothelial nitric oxide synthase production reverses vascular dysfunction and inflammation in the hindlimbs of a rat model of diabetes.

Authors:  A Riad; D Westermann; S Van Linthout; Z Mohr; S Uyulmaz; P M Becher; H Rütten; P Wohlfart; H Peters; H-P Schultheiss; C Tschöpe
Journal:  Diabetologia       Date:  2008-09-30       Impact factor: 10.122

8.  Inflammatory cytokines, endothelial markers and adhesion molecules in rheumatoid arthritis: effect of intensive anti-inflammatory treatment.

Authors:  Will Foster; David Carruthers; Gregory Y H Lip; Andrew D Blann
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

9.  Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.

Authors:  Kazuo Nakamura; Sho-ichi Yamagishi; Hisashi Adachi; Yayoi Kurita-Nakamura; Takanori Matsui; Takafumi Yoshida; Tsutomu Imaizumi
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354

10.  Plasma E-selectin levels can play a role in the development of diabetic retinopathy.

Authors:  Márta Kasza; J Meleg; J Vardai; B Nagy; E Szalai; J Damjanovich; A Csutak; B Ujhelyi; V Nagy
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-04       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.